Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taxoprexin in metastatic melanoma
NCT00249262Phase 2Completed
- Sponsor
- American Regent, Inc.
- Start
- Oct 2005
- Primary completion
- Apr 2007
- Modality
- Prodrugs/Conditional Activator Small Molecules
01
Overview
A Phase 2 trial of paclitaxel docosahexaenoic acid in melanoma, sponsored by American Regent, Inc.. Started Oct 2005; status: completed.
02
Drugs
paclitaxel docosahexaenoic acid
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00249262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00249262.